Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 358-365

  Grieco, Paolo ^a   Luca, Vincenzo ^b   Auriemma, Luigia ^a   Carotenuto, Alfonso ^a   Saviello, Maria Rosaria ^a   Campiglia, Pietro ^c   Barra, Donatella ^b   Novellino, Ettore ^a   Mangoni, Maria Luisa ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Alanine scanning; Antimicrobial peptides; Frog skin; Temporin

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN 1TA; TEMPORIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; FROG; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SKIN; STRUCTURE ACTIVITY RELATION;

AMPHIBIAN PROTEINS; ANIMALS; ANTI-INFECTIVE AGENTS; CIRCULAR DICHROISM; HEMOLYSIS; MICROBIAL SENSITIVITY TESTS; RANIDAE; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP;

ANURA; BACTERIA (MICROORGANISMS); FUNGI; NEGIBACTERIA; POSIBACTERIA;

EID: 79953787474     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1350     Document Type: Article

References (53)

1. Yang D, Chertov O, Oppenheim JJ. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell. Mol. Life Sci. 2001; 58: 978-989.
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
3. Nicolas P, Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 1995; 49: 277-304.
4. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55.
5. Bulet P, Hetru C, Dimarcq JL, Hoffmann D. Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 1999; 23: 329-344.
6. Hancock REW, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug. Targets Infect. Disord. 2002; 2: 79-83.
7. Easton DM, Nijnik A, Mayer ML, Hancock RE. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 2009; 27: 582-590.
8. Hadley EB, Hancock RE. Strategies for the discovery and advancement of novel cationic antimicrobial peptides. Curr. Top. Med. Chem. 2010; 8: 1872-1881.
9. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 2007; 64: 922-933.
10. Lehrer RI, Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 2002; 9: 18-22.
11. Ganz T. Defensins and other antimicrobial peptides: a historical perspective and an update. Comb. Chem. High Throughput Screen. 2005; 8: 209-217.
12. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106: 20-26.
13. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
14. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 2000; 164: 549-553.
15. Ding L, Yang L, Weiss TM, Waring AJ, Lehrer RI, Huang HW. Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 2003; 42: 12251-12259.
16. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1999; 1462: 55-70.
17. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
18. Park Y, Hahm KS. Antimicrobial peptides (AMPs): peptide structure and mode of action. J. Biochem. Mol. Biol. 2005; 38: 507-516.
19. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 1996; 242: 788-792.
20. Mangoni ML. Temporins, anti-infective peptides with expanding properties. Cell. Mol. Life Sci. 2006; 63: 1060-1069.
21. Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide. J. Biol. Chem. 2010; 285: 16880-16892.
22. Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J. The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae). Peptides 2009; 30: 273-282.
23. Ouellette AJ. Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin. Immunopathol. 2005; 27: 133-146.
24. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004; 75: 39-48.
25. Simmaco M, Mignogna G, Barra D. Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 1998; 47: 435-450.
26. Conlon JM, Kolodziejek J, Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta 2004; 1696: 1-14.
27. Bradbury AF, Smyth DG. Peptide amidation. Trends Biochem. Sci. 1991; 16: 112-115.
28. Mangoni ML, Maisetta G, Di Luca M, Gaddi LM, Esin S, Florio W, Brancatisano FL, Barra D, Campa M, Batoni G. Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant Nosocomial Bacterial Strains. Antimicrob. Agents Chemother. 2008; 52: 85-91.
29. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D, Simmaco M. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur. J. Biochem. 2000; 267: 1447-1454.
30. Mangoni ML, Marcellini HG, Simmaco M. Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin. J. Pept. Sci. 2007; 13: 603-613.
31. Rosenfeld Y, Barra D, Simmaco M, Shai Y, Mangoni ML. A synergism between temporins toward gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J. Biol. Chem. 2006; 281: 28565-28574.
32. Mangoni ML, Epand RF, Rosenfeld Y, Peleg A, Barra D, Epand RM, Shai Y. Lipopolysaccharide, a key molecule involved in the synergism between temporinsin inhibiting bacterial growth and in endotoxin neutralization. J. Biol. Chem. 2008; 283: 22907-229017.
33. Mangoni ML, Shai Y. Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification. Biochim. Biophys. Acta 2009; 1788: 1610-1619.
34. Carotenuto A, Malfi S, Saviello MR, Campiglia P, Gomez-Monterrey I, Mangoni ML, Gaddi LM, Novellino E, Grieco P. A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. J. Med. Chem. 2008; 51: 2354-2362.
35. Atherton E, Sheppard RC. Solid-phase Peptide Synthesis: A Practical Approach. IRL: Oxford; 1989.
36. Valenti P, Visca P, Antonini G, Orsi N. Antifungal activity of ovotransferrin towards genus Candida. Mycopathologia 1985; 89: 169-175.
37. Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 1984; 53: 595-623.
38. Unneberg P, Merelo JJ, Chacon P, Moran F. SOMCD: method for evaluating protein secondary structure from UV circular dichroism spectra. Proteins 2001; 42: 460-470.
39. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, Ludvigsen S, Raventos D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jorgensen SG, Sorensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005; 437: 975-980.
40. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 2005; 6: 57-64.
41. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis. 1987; 9: 1065-1078.
42. Rinaldi AC. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr. Opin. Chem. Biol. 2002; 6: 799-804.
43. Miele R, Ponti D, Boman HG, Barra D, Simmaco M. Molecular cloning of a bombinin gene from Bombina orientalis: detection of NF-kappaB and NF-IL6 binding sites in its promoter. FEBS Lett. 1998; 431: 23-28.
44. Mangoni ML, Miele R, Renda TG, Barra D, Simmaco M. The synthesis of antimicrobial peptides in the skin of Rana esculenta is stimulated by microorganisms. FASEB J. 2001; 15: 1431-1432.
45. Mangoni ML, Saugar JM, Dellisanti M, Barra D, Simmaco M, Rivas L. Temporins, small antimicrobial peptides with leishmanicidal activity. J. Biol. Chem. 2005; 280: 984-990.
46. Chen Q, Wade D, Kurosaka K, Wang ZY, Oppenheim JJ, Yang D. Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes. J. Immunol. 2004; 173: 2652-2659.
47. Aurell CA, Wistrom AO. Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS). Biochem. Biophys. Res. Commun. 1998; 253: 119-123.
48. Kamysz W, Mickiewicz B, Greber K, Rodziewicz-Motowidlo S. Conformational solution studies of the anti-microbial temporin A retro-analogues by using NMR spectroscopy. J. Pept. Sci. 2007; 13: 327-333.
49. Saviello MR, Malfi S, Campiglia P, Cavalli A, Grieco P, Novellino E, Carotenuto A. New insight into the mechanism of action of the temporin antimicrobial peptides. Biochemistry 2010; 49: 1477-1485.
50. Wade D, Silberring J, Soliymani R, Heikkinen S, Kilpelainen I, Lankinen H, Kuusela P. Antibacterial activities of temporin A analogs. FEBS Lett. 2000; 479: 6-9.
51. Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, Schinina ME, Simmaco M. Effects of temporins on molecular dynamics and membrane permeabilization in lipid vesicles. J. Pept. Res. 2001; 58: 213-220.
52. Wieprecht T, Dathe M, Beyermann M, Krause E, Maloy WL, MacDonald DL, Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 1997; 36: 6124-6132.
53. Wade D, Flock JI, Edlund C, Lofving-Arvholm I, Sallberg M, Bergman T, Silveira A, Unson C, Rollins-Smith L, Silberring J, Richardson M, Kuusela P, Lankinen H. Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept. Lett. 2002; 9: 533-543.